<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 66-year-old male received an implant of a dual-chamber implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) and was prescribed <z:chebi fb="0" ids="2663">amiodarone</z:chebi> (400 mg/day) </plain></SENT>
<SENT sid="1" pm="."><plain>The intra-thoracic impedance monitor in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> antecedently detected <z:chebi fb="0" ids="2663">amiodarone</z:chebi>-induced <z:hpo ids='HP_0011009'>acute</z:hpo> fibrosing <z:mp ids='MP_0010922'>alveolitis</z:mp> &gt;3 months prior to clinical symptoms </plain></SENT>
</text></document>